NARRATIVA PATHWAY · CUSTOMER STORY
Asphalion · Regulatory and scientific consultancy
Modernizing regulatory documentation with AI.
How Asphalion combines regulatory expertise with Narrativa AI agents to simplify document workflows and support life sciences teams.
Partner AsphalionWork Regulatory documentationSolution Narrativa Navigator
THE RESULTSRegulatory expertise.
Regulatory expertise.
AI-powered scale.
The partnership is helping teams produce first drafts faster, improve consistency in submissions, and reduce manual workload across regulatory workflows.
generation
requirements
workload
workflows
THE PROBLEM
Rising regulatory demands. More pressure on expert teams.
Asphalion is a global regulatory and scientific consultancy working with life sciences companies in a sector where precision, compliance, and speed are non-negotiable.
The growing complexity of drug development and increasing regulatory demands make document creation a significant burden for medical writing and regulatory affairs teams.
Organizations need clear, compliant narratives grounded in clinical data and aligned with global agency expectations—without adding more manual drafting, handoffs, and review workload.
THE SOLUTION
Pair regulatory expertise with AI-driven drafting.
Asphalion and Narrativa offer a hybrid approach: first-hand regulatory expertise combined with AI that transforms clinical data into clear, compliant narratives. Navigator understands regulatory structures and terminology and aligns outputs with EMA, FDA, and other global agency requirements.
Generate first drafts
Create regulatory documents automatically, leaving more time for expert review and quality control.
Build consistent outputs
Use data-driven content aligned with regulatory structures and terminology.
Simplify collaboration
Reduce manual workload and stakeholder handoffs across document workflows.
THE KPIS
Progress across regulatory workflows.
Faster drafting
First-draft generation helps accelerate document creation across therapeutic areas.
Submission consistency
Regulatory teams can prepare more consistent documents using structured, data-driven outputs.
Team efficiency
Reducing manual authoring gives experts more time for review, quality control, and higher-value work.
Scalable collaboration
The hybrid approach supports both large pharmaceutical companies and smaller biotechnology firms.
THE OUTCOME
A regulatory bottleneck becomes a competitive advantage.
From patient narratives to CSRs and TLFs, Narrativa’s platform creates audit-ready content from the first draft, helping accelerate submission timelines and improve the document lifecycle. The partnership is enabling regulatory teams to work with greater speed, consistency, and capacity.